Long-term changes in graft height after maxillary sinus floor elevation with different grafting materials: radiographic evaluation with a minimum follow-up of 4.5 years.
OBJECTIVE
To compare the vertical dimensional changes with regard to graft height in a long-term follow-up in patients treated with two different grafting materials used in maxillary sinus floor elevation procedures.


METHODS
Twenty consecutive patients were included. One group was grafted with autogenous bone from the mandible (chin area), and the other group was augmented with a 100% beta-tricalcium phosphate (beta-TCP). During a 4- to 5-year period, in each patient, at least five panoramic radiographs were made. These panoramic radiographs were used for morphometric measurements, at three different locations. The three locations were the first bone to implant contact at the distal side of the second most posterior implant (L1), halfway between this implant and the most posterior implant (L2) and the site 5 mm distal to the most posterior implant (L3). The measured vertical bone heights were evaluated to assess whether there was loss of height and, if so, whether the reduction in graft height occurred in an initial healing period or whether it was an ongoing process during the whole study period.


RESULTS
There is a statistically significant reduction of vertical bone height in time at all locations (P<0.001). The mean decrease of the total vertical height during the whole study period at the three different locations did not differ significantly for and between both grafting groups. Repeated measures analysis of variance showed that at location L1, the reduction in millimeters per month decreased in time (P=0.001). There was no difference between the grafting groups (P=0.958). Similar results were found on L2 (P=0.005). For L3, there also appeared to be a statistically significant difference in reduction in time in millimeters per month (P=0.004). There was no statistically significant difference in height reduction between locations L1, L2 and L3 for vertical bone height and graft height, respectively.


CONCLUSIONS
Both beta-TCP and mandibular bone grafts resulted in radiographic reduction of the vertical height over the 5-year period following maxillary sinus floor elevation. After an initial height reduction in the first 1.5 year, subsequent changes were minimal. No significant differences were observed between the two types of grafting material. There was no statistically significant difference in reduction between the three locations for vertical bone height and graft height, respectively.
Zijderveld
Steven A
SA
Department of Oral and Maxillofacial Surgery, VU University Medical Center/Academic Centre for Dentistry Amsterdam (ACTA), Amsterdam, The Netherlands. s.zijderveld@antonius.net
Schulten
Engelbert A J M
EA
Aartman
Irene H A
IH
ten Bruggenkate
Christiaan M
CM
D000328:Adult; D000368:Aged; D016301:Alveolar Bone Loss / Q000000981:diagnostic imaging; D000539:Alveolar Process / Q000000981:diagnostic imaging; D000540:Alveolar Ridge Augmentation / Q000379:methods*; D001672:Biocompatible Materials / Q000627:therapeutic use; D018786:Bone Substitutes / Q000627:therapeutic use*; D016025:Bone Transplantation / Q000379:methods*; D002130:Calcium Phosphates / Q000627:therapeutic use; D002508:Cephalometry; D003724:Dental Arch / Q000000981:diagnostic imaging / Q000601:surgery; D015921:Dental Implants; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008137:Longitudinal Studies; D008297:Male; D008437:Maxilla / Q000000981:diagnostic imaging / Q000601:surgery*; D008443:Maxillary Sinus / Q000000981:diagnostic imaging / Q000601:surgery*; D008875:Middle Aged; D011862:Radiography, Panoramic; D020858:Tissue and Organ Harvesting; D014182:Transplantation, Autologous
D001672:Biocompatible Materials; D018786:Bone Substitutes; D002130:Calcium Phosphates; D015921:Dental Implants; C485817:beta-tricalcium phosphate